Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
2011

Economic Impact of Dengue: A Review

Sample size: 43 publication Evidence: low

Author Information

Author(s): Mark E. Beatty, Philippe Beutels, Martin I. Meltzer, Donald S. Shepard, Joachim Hombach, Raymond Hutubessy, Damien Dessis, Laurent Coudeville, Benoit Dervaux, Ole Wichmann, Harold S. Margolis, Joel N. Kuritsky

Primary Institution: Pediatric Dengue Vaccine Initiative, International Vaccine Institute

Hypothesis

What is the economic burden of dengue and how can it inform vaccine development?

Conclusion

The economic literature on dengue is limited and often inconsistent, highlighting the urgent need for more targeted health economic research.

Supporting Evidence

  • Dengue causes an estimated 50 million infections and 20,000 deaths annually.
  • The economic literature on dengue is sparse and often conflicting.
  • Health economic research specific to dengue is urgently needed.

Takeaway

Dengue is a serious disease that costs a lot of money to treat, and we need better studies to understand how to prevent it, especially with vaccines.

Methodology

A systematic review of health economics studies related to dengue was conducted, involving searches of multiple databases and expert panel assessments.

Potential Biases

Potential bias due to reliance on published literature and expert opinions.

Limitations

The review primarily captured published studies, which may introduce publication bias.

Digital Object Identifier (DOI)

10.4269/ajtmh.2011.10-0521

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication